The ROE as of December 2024 (TTM) for Deep Medicine Acquisition Corp. (DMAQ) is 42.39%

According to Deep Medicine Acquisition Corp.’s latest financial reports and current stock price. The company's current ROE is 42.39%. This represents a change of 189.21% compared to the average of 14.66% of the last 4 quarters.

Deep Medicine Acquisition Corp. (DMAQ) Historical ROE (quarterly & annually)

How has DMAQ ROE performed in the past?

The mean historical ROE of Deep Medicine Acquisition Corp. over the last ten years is 219.67%. The current 42.39% ROE has changed -80.70% with respect to the historical average. Over the past ten years (40 quarters), DMAQ's ROE was at its highest in in the September 2021 quarter at 75.26%. The ROE was at its lowest in in the March 2023 quarter at -25.75%.

Deep Medicine Acquisition Corp. (DMAQ) ROE by Quarter and Year

Discovering the peaks and valleys of Deep Medicine Acquisition Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Deep Medicine Acquisition Corp. (DMAQ) Average ROE

How has DMAQ ROE performed in the past?

The current ROE of Deep Medicine Acquisition Corp. (DMAQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Deep Medicine Acquisition Corp. (DMAQ) ROE vs. Peers

How is DMAQ’s ROE compared to its peers?

Deep Medicine Acquisition Corp.’s ROE is less than Acri Capital Acquisition Corporation (1.05%), greater than Burtech Acquisition Corp. (-5.96%), greater than Compass Digital Acquisition Corp. (-13.35%), less than TKB Critical Technologies 1 (35.35%), less than Achari Ventures Holdings Corp. I (135.95%), less than AlphaVest Acquisition Corp (5.71%), less than Kingswood Acquisition Corp. (20.51%), less than Insight Acquisition Corp. (98.87%), less than Kingswood Acquisition Corp. (20.51%), greater than ClimateRock (-3.47%), greater than OmniLit Acquisition Corp. (-2.05%), greater than Manaris (2010) Corp. (-38.18%), less than Altimar Acquisition Corp. III (0%), less than AfterNext HealthTech Acquisition Corp. (0%), less than Alpha One Inc. (0%), greater than Portage Fintech Acquisition Corporation (-1.08%), greater than Nubia Brand International Corp. (-2.24%), less than ALSP Orchid Acquisition Corporation I (1.57%), greater than Ahren Acquisition Corp. (0.21%), less than null (10.68%),

Build a custom stock screener for Deep Medicine Acquisition Corp. (DMAQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Deep Medicine Acquisition Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Deep Medicine Acquisition Corp. (DMAQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Deep Medicine Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.